RecruitingNot ApplicableNCT06423430
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS
Sponsor
Abbott Medical Devices
Enrollment
100 participants
Start Date
Sep 11, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to evaluate the effectiveness and safety of bilateral stimulation of the subcallosal cingulate white matter (SCCwm) using Deep Brain Stimulation (DBS) as an adjunctive treatment of non-psychotic unipolar Major Depressive Disorder (MDD) in adults.
Eligibility
Min Age: 22 YearsMax Age: 70 Years
Inclusion Criteria4
- The patient must be diagnosed with non-psychotic unipolar Major Depressive Disorder.
- The patient must be in a major depressive episode for ≥12 months or have had at least 3 lifetime depressive episodes.
- The patient has tried and failed a minimum of four different types of antidepressant treatments as measured by a tool designed for this purpose.
- Depression medication and treatment regimen must be stable for a minimum of 4 weeks before the first baseline visit
Exclusion Criteria8
- Pregnant or those who plan to become pregnant during study
- Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that could limit participation in the study or interfere with adherence to the study protocol.
- Current or lifetime history of psychotic features in any Major Depressive Episode.
- Has an intracranial Central Nervous System disease that impairs motor, sensory or cognitive function or that requires intermittent or chronic medication.
- Significant acute suicide risk.
- Diagnosis of Substance Use Disorder or Alcohol Use Disorder without sustained remission (12 months or longer).
- Current and ongoing use of neurostimulation treatment that may interfere with DBS therapy/system.
- Treatment with another investigational device or investigational drugs.
Interventions
DEVICESham-stimulation
Sham-stimulation
DEVICEActive-stimulation
Active DBS
Locations(25)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06423430
Related Trials
Characterizing Dopamine Receptor Binding in Treatment Resistant Depression
NCT035377941 location
Disruptions of Brain Networks and Sleep by Electroconvulsive Therapy
NCT059057051 location
40 Hz Light Neurostimulation for Patients With Depression (FELIX)
NCT056802201 location
University of Iowa Interventional Psychiatry Service Patient Registry
NCT044809181 location
Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression
NCT071662891 location